ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 23 filers reported holding ADMA BIOLOGICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $74,000 | -62.1% | 20,000 | -50.0% | 0.00% | -62.5% |
| Q1 2017 | $195,000 | -61.9% | 40,000 | -60.0% | 0.01% | -68.0% |
| Q4 2016 | $512,000 | -39.6% | 100,000 | -14.5% | 0.02% | -51.9% |
| Q3 2016 | $847,000 | +0.1% | 117,000 | -17.7% | 0.05% | -20.0% |
| Q2 2016 | $846,000 | -27.9% | 142,155 | -2.0% | 0.06% | +27.5% |
| Q1 2016 | $1,173,000 | -9.1% | 145,000 | -9.4% | 0.05% | -42.7% |
| Q4 2015 | $1,291,000 | +0.3% | 160,000 | +3.9% | 0.09% | +56.1% |
| Q3 2015 | $1,287,000 | +54.5% | 154,000 | +71.1% | 0.06% | +72.7% |
| Q2 2015 | $833,000 | +60.2% | 90,000 | +69.5% | 0.03% | +43.5% |
| Q1 2015 | $520,000 | – | 53,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |